Impact of an exercise-induced increase in cardiac troponin I in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

American Journal of Cardiology

Volumn 90, Issue 5, 2002, Pages 547-550

  Schulz, Olaf ^a,c   Sigusch, Holger H ^b  

^a Heinrich Mann Hospital for Cardiac Rehabilitation   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c Cooperative Interventional Cardiology Spandau ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; EXERCISE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; KINETICS; LUNG CAPILLARY PRESSURE; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; CYTOKINES; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY WEDGE PRESSURE; STATISTICS; TROPONIN I;

EID: 0036711314     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02535-3     Document Type: Article

References (20)

1. La Vecchia L., Mezzena G., Ometto R., Finocchi G., Bedogni F., Soffiati G., Vincenzi M. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol. 80:1997;88-89.
2. Setsuta K., Seino Y., Takahashi N., Ogawa T., Sasaki K., Harada A., Takano T., Kishida H., Hayakawa H. Clinical significance of cardiac troponin T in patients with chronic heart failure. Am J Cardiol. 84:1999;608-611.
3. Rifai N., Douglas P., O'Toole M., Rimm E., Ginsburg G.S. Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii ironman triathlon. Am J Cardiol. 83:1999;1085-1089.
4. Schulz O., Kromer A. Cardiac troponin I - a potential marker of exercise intolerance in patients with moderate heart failure. Am Heart J. 144:2002;350-357.
5. Logeart D., Beyne P., Cusson C., Tokmakova M., Leban M., Guiti C., Bourgoin P., Cohen Solal A. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J. 141:2001;247-253.
6. Sato Y., Yamada T., Taniguchi R., Nagai K., Makiyama T., Okada H., Kataoka K., Ito H., Matsumori A., Sasayama S., Takatsu Y. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation. 103:2001;369-374.
7. Sobel B.E., LeWinter M.M. Ingenuous interpretation of elevated blood levels of macromolecular markers of myocardial injury a recipe for confusion . J Am Coll Cardiol. 35:2000;1355-1358.
8. Antman E.M. Troponin measurements in ischemic heart disease more than just a black and white picture . J Am Coll Cardiol. 38:2001;987-990.
9. Holmes D.R., Berger P.B. Troponisms, necrosettes, enzyme leaks, creatinine phosphokinase bumps, and infarctletts What's behind this new lexicon and what does it add? Circulation. 104:2001;627-629.
10. Ottani F., Galvani M., Nicolini F.A., Ferrini D., Pozzati A., Di Pasquale G., Jaffe A.S. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J. 140:2000;917-927.
11. Ng S.M., Krishnaswamy P., Morrisey R., Clopton P., Fitzgerald R., Maisel A.S. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. Am J Cardiol. 87:2001;994-999.
12. Jaffe A.S. Testing the wrong hypothesis the failure to recognize the limitations of troponin assays . J Am Coll Cardiol. 38:2001;999-1001.
13. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241.
14. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction a report from the Studies of Left Ventricular Dysfunction (SOLVD) . J Am Coll Cardiol. 27:1996;1201-1206.
15. Ferdinandy P., Danial H., Ambrus I., Rothery R.A., Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res. 87:2000;241-247.
16. Gulick T., Chung M.K., Pieper S.J., Lange L.G., Schreiner G.F. Interleukin I and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA. 86:1989;6753-6757.
17. Grossman G.B., Rohde L.E., Clausell N. Evidence for increased peripheral production of tumor necrosis factor-α in advanced congestive heart failure. Am J Cardiol. 88:2001;578-581.
18. Ono K., Matsomuri A., Shioi T., Furukawa Y., Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts. Possible implication in left ventricular remodeling. Circulation. 98:1998;149-156.
19. Kapadia S.R., Yakoob K., Nader S., Thomas J.D., Mann D.L., Griffin B.P. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol. 36:2000;208-212.
20. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., Mann D.L. Cytokines and cytokine receptors in advanced heart failure An analysis of the cytokine database from the vesnarinone trial (VEST) . Circulation. 103:2001;2055-2059.